Serum beta-2 microglobulin as a diagnostic biomarker for pediatric Epstein–Barr virus infections: a retrospective study
Frontiers in Pediatrics · 30.06.2026 · 14
DOI: 10.3389/fped.2026.1853250 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 30.06.2026. Verfasst von Sheng Cheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Affiliated Hospital 6 of Nantong University, Yancheng Third People's Hospital, Yancheng, Jiangsu, China. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study aims to evaluate serum beta-2 microglobulin (β2M) as a diagnostic biomarker for acute primary Epstein–Barr virus (EBV) infection in children, Additionally, serum vitamin D3 levels were compared between EBV-infected children and children with viral upper respiratory tract infection to explore their potential clinical relevance.
Methods
A total of 129 children with acute primary EBV infection were identified as the EBV group, while 130 children with viral upper respiratory tract infections in the same age group hospitalized during the same period were identified as the control group. The age, gender, and laboratory indicators of the two groups were analyzed and compared. Pearson's correlation was used to analyze the correlation between β2M and serum EBV-DNA concentration. The receiver operating characteristic (ROC) curve was drawn, and the threshold and area under the curve (AUC) of β2M for predicting the diagnosis of EBV infection were calculated.
Results
The white blood cell count, serum lactate dehydrogenase, and alanine aminotransferase levels in the EBV group were significantly than those in the control group ( P < 0.0001), and Serum β2M level were significantly higher in the EBV group than in the control group ( P < 0.001), while serum vitamin D3 levels were significantly lower ( P < 0.001). Pearson's correlation analysis showed a positive correlation between serum β2M levels and serum EBV-DNA load ( r = 0.469, P < 0.01). ROC curve analysis revealed that the AUC of serum β2M for diagnosing EBV infection was 0.907 (95% confidence interval 0.8723–0.9412; P < 0.01), with an optimal threshold of 3.3 mg/L, a specificity of 62.1%, and a sensitivity of 90.8%.
Conclusion
The serum β2M levels are significantly increased in the stage of primary EBV infection in children, and β2M appears to be a promising biomarker for predicting primary EBV infection. The serum vitamin D3 levels are significantly reduced in children with primary EBV infection, and the protective effect of vitamin D supplementation in those children warrants additional clinical exploration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Affiliated Hospital 6 of Nantong University, Yancheng Third People's Hospital, Yancheng, Jiangsu, China.
Zitieren
APA
Cheng, S., Pan, J., Wang, B., Cai, X., & Yin, T. (2026). Serum beta-2 microglobulin as a diagnostic biomarker for pediatric Epstein–Barr virus infections: a retrospective study. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1853250
Vancouver
Cheng S, Pan J, Wang B, Cai X, Yin T. Serum beta-2 microglobulin as a diagnostic biomarker for pediatric Epstein–Barr virus infections: a retrospective study. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1853250
BibTeX
@article{Cheng2026,
author = {Cheng, Sheng and Pan, Jingjing and Wang, Bing and Cai, Xulong and Yin, Tongjin},
title = {Serum beta-2 microglobulin as a diagnostic biomarker for pediatric Epstein–Barr virus infections: a retrospective study},
journal = {Frontiers in Pediatrics},
year = {2026},
volume = {14},
doi = {10.3389/fped.2026.1853250}
}
EUVIMED